MiNK Therapeutics Inc [NASDAQ: INKT] surged by $56.44 during the normal trading session on Friday and reaching a high of $76.0 during the day while it closed the day at $64.17.
MiNK Therapeutics Inc stock has also gained 787.38% of its value over the past 7 days. However, INKT stock has inclined by 745.45% in the 3 months of the year. Over the past six months meanwhile, it has gained 597.50% and gained 620.53% year-on date.
The market cap for INKT stock reached $255.76 million, with 3.97 million shares outstanding and 0.99 million shares in the current float. Compared to the average trading volume of 7.55K shares, INKT reached a trading volume of 47504750 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about MiNK Therapeutics Inc [INKT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INKT shares is $35.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INKT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
INKT stock trade performance evaluation
MiNK Therapeutics Inc [INKT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 787.38. With this latest performance, INKT shares gained by 746.77% in over the last four-week period, additionally plugging by 597.50% over the last 6 months – not to mention a rise of 820.79% in the past year of trading.
MiNK Therapeutics Inc [INKT]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -174.52%, with Return on Assets sitting at -174.52%.
Earnings per share (EPS) analysis for MiNK Therapeutics Inc [INKT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INKT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MiNK Therapeutics Inc go to 15.43%.
MiNK Therapeutics Inc [INKT]: Institutional Ownership
There are presently around $1.58%, or 6.17% of INKT stock, in the hands of institutional investors. The top three institutional holders of INKT stocks are: VANGUARD GROUP INC with ownership of 0.23 million shares, which is approximately 0.676%. LONGBOW FINANCE SA, holding 0.17 million shares of the stock with an approximate value of $$0.16 million in INKT stocks shares; and LONGBOW FINANCE SA, currently with $$0.12 million in INKT stock with ownership which is approximately 0.369%.
